局部前列腺癌大型随机III期CHHiP试验(CRUK/06/016)转化子研究中的组织样本采集方法学
本文介绍CHHiP试验(随机3216例局部前列腺癌患者至3种放疗分割方案)中转化研究Trans-CHHiP的组织采集方法,包括中心泌尿病理专家复核与招募中心病理医师Gleason分级组别的一致性比较。2012年8月至2014年4月从107个病理科采集2047例患者组织,中心复核与招募中心病理医师Gleason分级组别一致率为1854例中886例(47.8%)。
要点
- CHHiP试验随机3216例局部前列腺癌患者至3种放疗分割方案,Trans-CHHiP旨在识别分割敏感性的生物标志物。
- 2012年8月至2014年4月从107个病理科采集2047例患者组织样本。
- 招募中心病理医师与中心研究专用泌尿病理专家Gleason分级组别一致率为1854例中886例(47.8%)。
核心结论
- 该组织采集方法学使大型随机放疗试验成功采集2047例患者样本。
- 中心病理复核对于减少Gleason分级组别的主观性及分级偏移的影响具有重要意义。
研究设计与样本
- 本文为CHHiP试验(随机3216例局部前列腺癌患者至3种放疗分割方案)内转化研究Trans-CHHiP的方法学介绍,涵盖组织采集流程、中心研究专用泌尿病理专家复核及与招募中心病理医师Gleason分级组别的比较。
主要发现
- 2012年8月至2014年4月从107个病理科采集2047例患者组织。
- 招募中心病理医师与中心研究专用泌尿病理专家Gleason分级组别一致率为1854例中886例(47.8%)。
- 积极追查样本的临床试验单位与定期审查进度的中心Trans-CHHiP小组对样本采集成功至关重要。
临床怎么用
- 关键经验包括:在主试验招募患者时需前瞻性获取组织采集同意,以及将材料转移协议(MTA)整合到初始试验站点协议中的重要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This article presents the methodology for tissue sample collection in Trans-CHHiP, the main translational study within the CHHiP (Conventional or Hypofractionated High dose intensity modulated radiotherapy in Prostate cancer, ISRCTN 97182923) trial. The CHHiP trial randomised 3216 men with localised prostate cancer to 3 different radiotherapy fractionation schedules. Trans-CHHiP aims to identify biomarkers of fraction sensitivity. METHODS: We outline the process of tissue collection, including central review by a study-specific specialist uropathologist and comparison of the centrally-assigned Gleason grade group with that assigned by the recruiting-centre pathologist. RESULTS: 2047 patients provided tissue from 107 pathology departments between August 2012 and April 2014. A highly motivated Clinical Trials Unit chasing samples and a central Trans-CHHiP group that regularly reviewed progress were important for successful sample collection. Agreement in Gleason grade group assigned by the recruiting centre pathologist and the central study-specific uropathologist occurred in 886 out of 1854 (47.8%) cases. Key lessons learned were the need for prospective consent for tissue collection when recruiting patients to the main trial, and the importance of Material Transfer Agreement (MTA) integration into the initial trial site agreement. CONCLUSIONS: This methodology enabled collection of 2047 patient samples from a large randomised radiotherapy trial. Central pathological review is important to minimise subjectivity in Gleason grade grouping and the impact of grade shift.
引用
- Wilkins A, Stuttle C, Hassan S, et al. Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer. Clin Transl Radiat Oncol. 2018. PMID: 29928699. doi:10.1016/j.ctro.2018.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。